MDRejuvena is dedicated to and passionate about providing products that rejuvenate, enhance and maintain skin health for the patients of physicians and skincare professionals worldwide.
Meet The Team
President and CEO
Randy brings over 20 years of management and commercial experience in the dermatology industry with more than 15 years focused on the development and marketing of aesthetic skincare products. Most recently, Randy was President of Sente, Inc and prior to that Vice President of Sales and Marketing at PrecisionMD, the aesthetic division of Precision Dermatology, where he was responsible for leading worldwide commercialization of the PrecisionMD portfolio. He has held management roles with a number of companies during their start-up phase within the dermatology marketplace including SkinMedica and Celfix Cosmeceuticals in which he was Co-Founder and Owner.
Michael has over 25 years of experience in senior financial and operational roles. Over his career he has more than $100 million in private and public equity and debt capital. He was most recently the CFO/COO for Sente, Inc., a science-based luxury skin care company whose products are sold through physician-dispensed channels. His prior experience includes being the CFO/COO for Gunnar Optics, the market leader in the Technology / Digital Performance Eyewear Category; Orange 21, a leading provider of eyewear products to the action sports and youth markets where he led an IPO on Nasdaq in an oversubscribed round; Odyssey Golf where as VP/General Manager he managed Odyssey Golf through their rapid growth period from $6 million to over $60 million in sales in two years and achieved the global market share leader in the putter category. Odyssey was sold to Callaway Golf at a significant premium. He started his career with KPMG, LLP.
Senior Vice President, Research, Product & Business Development
Vince, a clinical pharmacist by training, has 12 years of clinical pharmacy practice and research experience in large university hospital settings, including 7 years on a major university faculty. Over 25 years of experience in public and private pharmaceutical and biomedical companies in various management positions, including licensing/business development, strategic planning, and R&D. Expertise in both technical and commercial aspects including in- and out-licensing of products and technologies, strategy development and implementation, and operational management. Broad based experience in both medical and aesthetic dermatology. Served as a consultant for several dermatology and cosmetic companies including SkinMedica (9 years including serving as interim head of R&D), Intendis, Intrepid Therapeutics, Adar Sciences, Colorescience and NuFace.
Director of Domestic Sales
Greg comes to MDRejuvena with over 22 years of experience in the dermatology and aesthetic skin care industries. Greg was previously a Regional Sales Manager at Sente Labs, a luxury skin care company. Prior experience includes Pierre Fabre where he was the Western Regional Manager, Regional Manager at Skinmedica, Regional Manager at Stiefel Laboratories, and a sales rep at Glaxo Dermatology, a division of GlaxoWellcome.
Board of Directors
Chairman and CEO of Hale BioPharma Ventures, LLC, focused on the formation and development of biotechnology, specialty pharma, diagnostic and medical device companies. Co-Founder and Chairman of SkinMedica that sold to Allergan. Past Chairman of Santarus which sold to Salix Pharmaceuticals in 2014, Micromet which sold to Amgen, and Somaxon Pharmaceuticals prior to its sale to Pernix. Involved in a number of life sciences companies including Hybritech, Viagene, Gensia Sicor, Colorescience, Ridge Diagnostics, Recros Medica, Dermata Therapeutics and Skylit. He was also a co-founder of Cadence, Evoke, Elevation and Zogenix.
Co-Founder and CEO of SkinMedica from 2001 to 2008. Past President of Allergan Skin Care. He has also served as President and CEO of several companies including Arcturus Pharmaceutical Corporation and Epoulon, Inc., two dermatology companies, and Head of J&J Ortho Dermatologic Division. He has been a Director of Foamix Pharmaceuticals Ltd., SkinMedica, Restorgenex Corporation.
William Roper Jr.
Has held a number of executive positions including 17 years as EVP of SAIC, Inc., a diversified science and technology services organization, whose annual revenues grew from less than $1 Billion to nearly $9 Billion. He also served as President and CEO of Verisign, Inc., the leading global provider of internet infrastructure and security services and a member of the NASDAQ 100, where he was responsible for restructuring and repositioning the company. He was a Director at SkinMedica from 2001 – 2013.
Gerald ("Gerry") Proehl
Founder of Dermata Therapeutics, LLC and serves as its President and CEO. He was the President / CEO and Director at Santarus Inc. where he developed several successful pharmaceutical products. Santarus was sold to Salix for $2.6 billion. He also held executive positions in sales and marketing at Hoechst Marion Roussel, Inc., a global pharmaceutical company. He has been an Independent Director of Tenax Therapeutics, Inc., Auspex Pharmaceuticals, Inc., Sophiris Bio, Inc., and Ritter Pharmaceuticals, Inc., Oxygen Biotherapeutics, Inc., Kinetek Sports, Patara Pharma Inc., Dermata Therapeutics, LLC., DepoMed Inc.
Follow us on social media for instant updates, product launches and news. For more in-depth stories, corporate news and brand updates, check back here.